A detailed history of Smith & Howard Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Smith & Howard Wealth Management, LLC holds 1,315 shares of ABBV stock, worth $219,933. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,315
Previous 1,315 -0.0%
Holding current value
$219,933
Previous $203,000 17.73%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $180,944 - $203,785
1,315 New
1,315 $203,000
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $6,796 - $7,827
-47 Reduced 3.25%
1,397 $222,000
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $199,719 - $239,516
1,444 New
1,444 $233,000
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $173,951 - $221,149
-1,264 Closed
0 $0
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $166,822 - $206,980
1,264 New
1,264 $205,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Smith & Howard Wealth Management, LLC Portfolio

Follow Smith & Howard Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith & Howard Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith & Howard Wealth Management, LLC with notifications on news.